Imposing a duty on health care facilities to provide patients with autologous blood transfusions and direct allogeneic blood transfusions.
Impact
If enacted, HB 1997 will impose new regulations on healthcare facilities requiring them to accommodate specific blood transfusion methods prior to scheduled procedures. Facilities must allow individuals to notify them of their intention to provide autologous blood or arrange direct allogeneic blood donations at least 72 hours in advance of the medical procedure. This change may necessitate adjustments in protocols and patient handling within these facilities, as they reconcile existing practices with the new directives outlined in the bill.
Summary
House Bill 1997 is titled the Autologous and Direct Allogeneic Blood Transfusion Act and establishes a duty on healthcare facilities within Pennsylvania to facilitate autologous and direct allogeneic blood transfusions for patients undergoing medical procedures. The bill aims to mitigate the risks associated with receiving allogeneic blood transfusions from donors, such as transfusion reactions and the potential transmission of infectious diseases. By enabling patients to utilize their own blood or have blood from specified donors, the bill seeks to enhance patient safety and autonomy in medical care.
Contention
While the bill focuses on improving patient safety through the promotion of autologous blood transfusions, concerns may arise around the logistics and potential increased workload for healthcare facilities to comply with these new mandates. Stakeholders may debate the financial implications of implementing the bill, including the cost of required procedural changes, and whether such mandates might limit patients' options if healthcare facilities choose to circumvent the new requirements due to operational concerns.
Requiring health care facilities to provide autologous blood transfusions and direct allogeneic blood transfusions to individuals under certain circumstances.
Providing for patient election for donation and use of autologous blood; providing for disclosure of vaccination status in blood transfusions and requiring informed consent; and imposing duties on the Department of Health.
Urging the Congress of the United States to establish policies that would provide greater access to blood transfusions for hospice patients with blood cancer.
Adds to existing law to provide for disclosure and labeling of certain blood intended for blood transfusions and to provide that a person receiving a blood transfusion shall have the right to request blood based on vaccination status of the donor.
Urging the Congress of the United States to establish policies that would provide greater access to blood transfusions for hospice patients with blood cancer.
"Gary Letizia Pre-Hospital Blood Transfusion Act"; authorizes advanced life support providers, under medical oversight, to administer blood products to patients in pre-hospital settings, and establishes certain reimbursement for such providers.
Requiring health care facilities to provide autologous blood transfusions and direct allogeneic blood transfusions to individuals under certain circumstances.
"Gary Letizia Pre-Hospital Blood Transfusion Act"; authorizes advanced life support providers, under medical oversight, to administer blood products to patients in pre-hospital settings, and establishes certain reimbursement for such providers.
Providing for patient election for donation and use of autologous blood; providing for disclosure of vaccination status in blood transfusions and requiring informed consent; and imposing duties on the Department of Health.